Elevated Adiponectin Levels Suppress Perivascular and Aortic Inflammation and Prevent AngII-induced Advanced Abdominal Aortic Aneurysms

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wågsäter, Dick ^a   Vorkapic, Emina ^a   Van Stijn, Caroline M W ^b   Kim, Jason ^b   Lusis, Aldons J ^b   Eriksson, Per ^c   Tangirala, Rajendra K ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988472348     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31414     Document Type: Article

References (51)

1. Nordon, I. M., Hinchliffe, R. J., Loftus, I. M. & Thompson, M. M. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nature reviews. Cardiology 8, 92-102, doi: 10. 1038/nrcardio. 2010. 180 (2011).
2. Golledge, J., Muller, J., Daugherty, A. & Norman, P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arteriosclerosis, thrombosis, and vascular biology 26, 2605-2613, doi: 10. 1161/01. ATV. 0000245819. 32762. cb (2006).
3. Shimizu, K., Mitchell, R. N. & Libby, P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology 26, 987-994, doi: 10. 1161/01. ATV. 0000214999. 12921. 4f (2006).
4. Davis, F. M., Rateri, D. L. & Daugherty, A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 100, 1498-1505, doi: 10. 1136/heartjnl-2014-305648 (2014).
5. Tilson, M. D. Atherosclerosis and aneurysm disease. Journal of vascular surgery 12, 371-372 (1990).
6. Johnsen, S. H., Forsdahl, S. H., Singh, K. & Jacobsen, B. K. Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromso study. Arteriosclerosis, thrombosis, and vascular biology 30, 1263-1268, doi: 10. 1161/ ATVBAHA. 110. 203588 (2010).
7. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867, doi: 10. 1038/nature05485 (2006).
8. Yoshida, S., Fuster, J. J. & Walsh, K. Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. Atherosclerosis 235, 339-346, doi: 10. 1016/j. atherosclerosis. 2014. 05. 923 (2014).
9. Tao, M. et al. Locally applied leptin induces regional aortic wall degeneration preceding aneurysm formation in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 33, 311-320, doi: 10. 1161/ATVBAHA. 112. 300543 (2013).
10. Golledge, J., Clancy, P., Jamrozik, K. & Norman, P. E. Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study. Circulation 116, 2275-2279, doi: 10. 1161/CIRCULATIONAHA. 107. 717926 (2007).
11. van Stijn, C. M., Kim, J., Barish, G. D., Tietge, U. J. & Tangirala, R. K. Adiponectin Expression Protects against Angiotensin IIMediated Inflammation and Accelerated Atherosclerosis. PloS one 9, e86404, doi: 10. 1371/journal. pone. 0086404 (2014).
12. Berg, A. H. & Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circulation research 96, 939-949, doi: 10. 1161/01. RES. 0000163635. 62927. 34 (2005).
13. Persson, J. et al. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. Journal of internal medicine 268, 194-205, doi: 10. 1111/j. 1365-2796. 2010. 02247. x (2010).
14. Holland, W. L. et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature medicine 17, 55-63, doi: 10. 1038/nm. 2277 (2011).
15. Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature medicine 13, 332-339, doi: 10. 1038/nm1557 (2007).
16. van Stijn, C. M., Kim, J., Lusis, A. J., Barish, G. D. & Tangirala, R. K. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 29, 636-649, doi: 10. 1096/fj. 14-253831 (2015).
17. Pajvani, U. B. et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. The Journal of biological chemistry 279, 12152-12162, doi: 10. 1074/jbc. M311113200 (2004).
18. Daugherty, A. & Cassis, L. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor ?/? mice. Annals of the New York Academy of Sciences 892, 108-118 (1999).
19. Thompson, R. W., Liao, S. & Curci, J. A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coronary artery disease 8, 623-631 (1997).
20. Curci, J. A. & Thompson, R. W. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? The Journal of clinical investigation 114, 168-171, doi: 10. 1172/JCI22309 (2004).
21. Lopez-Candales, A. et al. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. The American journal of pathology 150, 993-1007 (1997).
22. Cassis, L. A., Rateri, D. L., Lu, H. & Daugherty, A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arteriosclerosis, thrombosis, and vascular biology 27, 380-386, doi: 10. 1161/01. ATV. 0000254680. 71485. 92 (2007).
23. Swedenborg, J., Mayranpaa, M. I. & Kovanen, P. T. Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology 31, 734-740, doi: 10. 1161/ATVBAHA. 110. 213157 (2011).
24. Kazi, M. et al. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arteriosclerosis, thrombosis, and vascular biology 25, 1341-1346, doi: 10. 1161/01. ATV. 0000166601. 49954. 21 (2005).
25. Sun, J. et al. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation 120, 973-982, doi: 10. 1161/CIRCULATIONAHA. 109. 849679 (2009).
26. Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. The Journal of clinical investigation 105, 1641-1649, doi: 10. 1172/JCI8931 (2000).
27. Maki, J. M. et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106, 2503-2509 (2002).
28. Rowe, D. W., McGoodwin, E. B., Martin, G. R. & Grahn, D. Decreased lysyl oxidase activity in the aneurysm-prone, mottled mouse. The Journal of biological chemistry 252, 939-942 (1977).
29. Juvonen, J. et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arteriosclerosis, thrombosis, and vascular biology 17, 2843-2847 (1997).
30. Golledge, A. L., Walker, P., Norman, P. E. & Golledge, J. A systematic review of studies examining inflammation associated cytokines in human abdominal aortic aneurysm samples. Disease markers 26, 181-188, doi: 10. 3233/DMA-2009-0629 (2009).
31. Police, S. B., Thatcher, S. E., Charnigo, R., Daugherty, A. & Cassis, L. A. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arteriosclerosis, thrombosis, and vascular biology 29, 1458-1464, doi: 10. 1161/ATVBAHA. 109. 192658 (2009).
32. Rateri, D. L. et al. Prolonged infusion of angiotensin II in apoE(?/?) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. The American journal of pathology 179, 1542-1548, doi: 10. 1016/j. ajpath. 2011. 05. 049 (2011).
33. Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. The Journal of clinical investigation 105, 1605-1612, doi: 10. 1172/JCI7818 (2000).
34. Fujiwara, Y. et al. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. International journal of molecular medicine 22, 703-708 (2008).
35. Kaschina, E. et al. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. Journal of hypertension 26, 2361-2373, doi: 10. 1097/HJH. 0b013e328313e547 (2008).
36. Jones, G. T. et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arteriosclerosis, thrombosis, and vascular biology 28, 764-770, doi: 10. 1161/ATVBAHA. 107. 155564 (2008).
37. Freestone, T. et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arteriosclerosis, thrombosis, and vascular biology 15, 1145-1151 (1995).
38. Yoshimura, K. et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nature medicine 11, 1330-1338, doi: 10. 1038/nm1335 (2005).
39. Onoda, M. et al. Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm. Atherosclerosis 208, 366-369, doi: 10. 1016/j. atherosclerosis. 2009. 07. 036 (2010).
40. Knox, J. B., Sukhova, G. K., Whittemore, A. D. & Libby, P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95, 205-212 (1997).
41. Zieman, S. J., Melenovsky, V. & Kass, D. A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arteriosclerosis, thrombosis, and vascular biology 25, 932-943, doi: 10. 1161/01. ATV. 0000160548. 78317. 29 (2005).
42. Leskinen, M. J. et al. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling. Experimental cell research 312, 1289-1298, doi: 10. 1016/j. yexcr. 2005. 12. 033 (2006).
43. Mayranpaa, M. I. et al. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. Journal of vascular surgery 50, 388-395; discussion 395-386, doi: 10. 1016/j. jvs. 2009. 03. 055 (2009).
44. Lindstedt, K. A., Mayranpaa, M. I. & Kovanen, P. T. Mast cells in vulnerable atherosclerotic plaques-a view to a kill. Journal of cellular and molecular medicine 11, 739-758, doi: 10. 1111/j. 1582-4934. 2007. 00052. x (2007).
45. Wang, Y. & Shi, G. P. Mast cell chymase and tryptase in abdominal aortic aneurysm formation. Trends in cardiovascular medicine 22, 150-155, doi: 10. 1016/j. tcm. 2012. 07. 012 (2012).
46. Schonbeck, U., Sukhova, G. K., Gerdes, N. & Libby, P. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. The American journal of pathology 161, 499-506, doi: 10. 1016/S0002-9440(10)64206-X (2002).
47. Frostegard, J. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145, 33-43 (1999).
48. Xiong, W., Zhao, Y., Prall, A., Greiner, T. C. & Baxter, B. T. Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. Journal of immunology 172, 2607-2612 (2004).
49. Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nature reviews. Immunology 11, 723-737, doi: 10. 1038/nri3073 (2011).
50. Watanabe, S. et al. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Clinical therapeutics 28, 1677-1685, doi: 10. 1016/j. clinthera. 2006. 10. 012 (2006).
51. Takata, Y. et al. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 105, 4277-4282, doi: 10. 1073/pnas. 0708647105 (2008).